Cited by 328Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record.

Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization

Birdsall, Mary A., Farquhar, Cynthia M., White, Harvey D.·1997·Annals of Internal Medicine

DOI 10.7326/0003-4819-126-1-199701010-00005

Open this paper in CoChat — free account

Abstract

BACKGROUND: Women with polycystic ovaries have associated risk factors for coronary artery disease. It is unknown whether women with more extensive coronary artery disease are more likely to have polycystic ovaries. OBJECTIVE: To determine whether women who have more extensive coronary artery disease as seen on coronary angiography are more likely to have polycystic ovaries appearing on ultrasonography than are women with less severe coronary disease. DESIGN: Prevalence study of women who had had coronary angiography. SETTING: Women referred for coronary angiography for assessment of chest pain or valvular disease in Auckland, New Zealand, during a 2-year period. PATIENTS: 143 women 60 years of age or younger who had had coronary angiography. Women who had previously had bilateral oophorectomy were excluded. MEASUREMENTS: The extent of coronary artery disease assessed by quantitative angiography was compared with the presence or absence of polycystic ovaries. Pelvic ultrasonography was done without knowledge of the extent of coronary artery disease. Assessment of angiograms was blinded. Insulin resistance and gonadotropin, testosterone, and serum lipid levels were also measured. RESULTS: Polycystic ovaries were found in 42% of women and were associated with hirsutism; previous hysterectomy; higher free testosterone, triglyceride, and C-peptide levels; and lower high-density lipoprotein cholesterol levels. Women with polycystic ovaries had more extensive coronary artery disease than women with normal ovaries (number of segments with > 50% stenosis, 1.7 [95% CI, 1.1 to 2.3] compared with 0.82 [CI, 0.54 to 1.1]; P < 0.01). On logistic regression analysis, the extent of coronary artery disease (P = 0.032) and family history of heart disease (P = 0.022) were predictors of the presence of polycystic ovaries. CONCLUSIONS: In women having coronary angiography, those with more extensive coronary artery disease were more likely to have polycystic ovaries on ultrasonography than were those with less extensive disease. Visualization of polycystic ovaries by sonography was associated with distinct metabolic and endocrine abnormalities. Further study is required to evaluate whether surgery or hormone replacement therapy can modify the risk.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-126-1-199701010-00005

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 328

Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
“Myocardial infarction was recorded to be seven times more likely in patients with histopathological evidence of PCO,(155) and cardiac catheterization studies have shown more extensive coronary artery disease in these patients than in women with normal ovaries.(158) Furthermore, significant subclinical carotid atherosc…”
Background
Introduction and history of polycystic ovary syndrome
Farquhar, C. M. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.002 · Cited by 17
Self-citation
Insulin Resistance: Causes and Consequences
Bloomgarden, Z. T. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(04)65001-x · Cited by 16
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B. G. A., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565 · Cited by 16
Predictors of Endothelial Dysfunction in Young Women With Polycystic Ovary Syndrome
Kravariti, M., Naka, K. Κ., Kalantaridou, S., Kazakos, N., Katsouras, C. S., Makrigiannakis, A., Paraskevaidis, E. A., Chrousos, G. P., Tsatsoulis, A. A., & Michalis, L. K. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000206323.83912.31 · Cited by 15
“In a study of 143 women undergoing cardiac catheterization, ultrasound polycystic ovary appearance was detected in 42% of those; these patients more frequently exhibited extensive coronary artery disease (8).”
Background
Lipid Parameters in Patients with Polycystic Ovary Syndrome
Iuhas, C. I., Costin, N., & Mihu, D. (2012) · Applied Medical Informatics (University of Medicine and Pharmacy Cluj-Napoca) · Cited by 15
Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
Srikanthan, P., Korenman, S. G., & Davis, S. S. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.001 · Cited by 14
LDL Species Heterogeneity in the Atherogenic Dyslipidemia of Polycystic Ovary Syndrome
Doi, S. A. R., Abbas, J. M. K., Parkinson, L., Chakraborty, J., & Akanji, A. O. (2008) · American Journal of Clinical Pathology · doi:10.1309/e7egttvcrfvba7ec · Cited by 15
RETRACTED: Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance
El-Kannishy, G. M., Kamal, S., Mousa, A. A., Saleh, O., Badrawy, A. E., El-Farahaty, R. M., & Shokeir, T. A. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2009.08.001 · Cited by 13
Retracted
Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
Baillargeon, J., Iuorno, M. J., & Nestler, J. E. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00003 · Cited by 14
HORMONE REPLACEMENT THERAPY AND CORONARY HEART DISEASE
Kuller, L. H. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70213-3 · Cited by 14
Mechanisms Involved in Metformin Action in the Treatment of Polycystic Ovary Syndrome
Motta, A. B. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058101 · Cited by 13
Potential Utility of Insulin Sensitizers in the Treatment of Patients with Polycystic Ovary Syndrome
Bayram, F., Ünlühızarcı, K., & Keleştimur, F. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201010-00005 · Cited by 12
Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome
Deveer, R., Üstün, Y. E., Uysal, S., Su, F. A., Sarıaslan, S., Gülerman, C., & Mollamahmutoğlu, L. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.650758 · Cited by 12
Polycystic ovary syndrome
Kovanci, E., & Buster, J. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.068 · Cited by 16
Ascorbic Acid and Alpha-Tocopherol Contribute to the Therapy of Polycystic Ovarian Syndrome in Mouse Models
Bafor, E. E., Uchendu, A. P., Osayande, O. E., Omoruyi, O., Omogiade, U. G., Panama, E. E., Elekofehinti, O. O., Oragwuncha, E. L., & Momodu, A. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00273-9 · Cited by 13
Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome
MEYER, C., TALBOT, M., & Teede, H. J. (2005) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2005.00372.x · Cited by 12
Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation
Vanky, E., Salvesen, K. Å., Hjorth‐Hansen, H., Bjerve, K. S., & Carlsen, S. M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.08.036 · Cited by 12
Long-term health consequences of polycystic ovary syndrome
Κousta, E., & Franks, S. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.007 · Cited by 11
Is reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?
Gharakhani, M., Neghab, N., & Farimani, M. S. (2011) · PubMed Central · Cited by 11
Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction
Distelmaier, K., Schrutka, L., Wurm, R., Seidl, V., Arfsten, H., Cho, A., Manjunatha, S., Perkmann, T., Strunk, G., Lang, I. M., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.037 · Cited by 12
New approaches to insulin resistance in polycystic ovarian syndrome
Davison, R. M. (1998) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199806000-00003 · Cited by 12
Cardiac Nitric Oxide Synthases and Na+/K+-ATPase in the Rat Model of Polycystic Ovary Syndrome Induced by Dihydrotestosterone
Tepavčević, S., Milutinović, D. V., Μacut, D., Stanišić, J., Nikolič, M., Antić, I. B., Rodaljević, S., Bjekić-Macut, J., Matić, G. M., & Korićanac, G. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1548929 · Cited by 11
“Women with PCOS have increased arterial lesions in their coronary vessels (Birdsall et al., 1997), while data on increased frequency of myocardial infarction in PCOS women are controversial (Schmidt et al.”
Background
Metabolic Consequences of Obesity
Hu, F. B. (2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195312911.003.0008 · Cited by 11
QT Dispersion in Patients with Polycystic Ovary Syndrome.
Alpaslan, M., Onrat, E., Yılmazer, M., et al. (2002) · Japanese Heart Journal · doi:10.1536/jhj.43.487 · Cited by 11
Subclinical left ventricular dysfunction in women with polycystic ovary syndrome: an observational study
Erdoğan, E., Akkaya, M., Bacaksız, A., Taşal, A., Turfan, M., Kul, Ş., Sönmez, O., Vatankulu, M. A., Ertaş, G., Batmaz, G., et al. (2013) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2013.196 · Cited by 11
“It has been estimated that myocardial infarction is seven times more likely in patients with PCOS (19), and cardiac catheterization studies have shown more extensive coronary artery disease in these patients than in women with normal ovaries (20).”
Background
Metformin-Diet Ameliorates Coronary Heart Disease Risk Factors and Facilitates Resumption of Regular Menses in Adolescents with Polycystic Ovary Syndrome
Glueck, C. J., Goldenberg, N., & Wang, P. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.9.815 · Cited by 10
Insulin resistance: what is its role in the polycystic ovary syndrome?
Moghetti, P. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00002 · Cited by 10
The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index
Rocha, A. L. L., Baêta, T., Nazareth, I. R., Costa, J. M., Caporalli, J. D., Oliveira, M. A., Couto, M. G., Azevedo, R. C., Comim, F. V., Oliveira, F. R., et al. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07328-7 · Cited by 9
Polcystic ovary syndrome and implications for the menopause
Norman, R. J., & McVeigh, E. (1999) · Climacteric · doi:10.3109/13697139909025578 · Cited by 9
Ovarian volumes among women with endometrial carcinoma: Associations with risk factors and serum hormones
Sherman, M. E., Madigan, M. P., Lacey, J. V., García‐Closas, M., Potischman, N. A., Carreon, J. D., Hartge, P. A., & Brinton, L. A. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.061 · Cited by 9
“One small analysis suggests that polycystic ovaries, hyperandrogenemia and hirsutism may be found after menopause [26].”
Background
Polycystic Ovarian Syndrome
Legro, R. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50030-6 · Cited by 9
Fetuina A u szczupłych i otyłych kobiet z zespołem policystycznych jajników
Kozakowski, J., Jeske, W., & Zgliczyński, W. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0051 · Cited by 9
“drogenism may be specific risk factors for developing atherothrombosis [16, 17].”
Background
Effects of Hyperinsulinemia on vascular blood flows in experimental obesity
Villa, E., González-Albarrán, O., Rábano, A., & García‐Robles, R. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00045-x · Cited by 9
The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes
Cho, L. W., Jayagopal, V., Kilpatrick, E. S., & Atkin, S. L. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008146 · Cited by 8
Cardiovascular health and menopause in aging women with polycystic ovary syndrome
Helvacı, N., & Yıldız, B. O. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1719067 · Cited by 8
“In earlier studies, hirsutism [47] and visualization of polycystic ovaries by ultrasonography [48] have been reported to be associated with coronary artery disease (CAD) in women having coronary angiography.”
Background
Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome
Xu, N., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.158 · Cited by 8
Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome
Vryonidou, A., Παπαθεοδώρου, Α., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou‐Asteriou, A. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197798.32867.0b · Cited by 8
Salusins, newly identified regulators of hemodynamics and mitogenesis, increase in polycystic ovarian syndrome
Çelik, Ö., Yılmaz, E., Çelik, N., et al. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.706667 · Cited by 8
Invited Commentary: Acne in Adolescence—Protecting the Heart but Damaging the Prostate Later in Life?
Ford, E. S., & Liu, S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi148 · Cited by 8
“In a crosssectional study of 143 women aged 60 years or less from New Zealand, those with polycystic ovarian syndrome had more extensive coronary heart disease on angiography than did women with normal ovaries (32).”
Background
The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome
Demirelli, S., Değirmenci, H., Ermiş, E., İnci, S., Nar, G., Ayhan, M. E., Fırtına, S., Hamur, H., & Durmaz, Ş. A. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.552 · Cited by 7
“In comparing PCOS patients to women with normal ovaries, many studies have reported that women with PCOS are seven 7 times more likely to have a myocardial infarction and common coronary artery disease [20].”
Background
Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
Gabrielli, L., de Almeida, M. D. C. C., & Aquino, E. M. L. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.04.013 · Cited by 7
Polycystic ovarian disease: an overview
Kovacs, G. T. (2004) · Reviews in Gynaecological Practice · doi:10.1016/j.rigp.2004.01.003 · Cited by 7
Vascular Compliance in Women With Polycystic Ovary Syndrome and Healthy Women
Muneyyirci‐Delale, O., Winer, N., Oklander, V., et al. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06454.x · Cited by 7
Effect of Lifestyle Modification and Metformin Therapy on Emerging Cardiovascular Risk Factors in Overweight Indian Women with Polycystic Ovary Syndrome
Rajagopal, G., Reddy, A., Harinarayan, C. V., Suresh, V., Bitla, A. R. R., Rao, S. P. V. L. N., & Sachan, A. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0127 · Cited by 8
Perfil lipídico en mujeres obesas y no obesas con síndrome de ovarios poliquísticos tratadas con metformina
Quintero-Castillo, D., Luz-Araujo, H., Guerra-Velásquez, M., Reyna‐Villasmil, E., Bolívar, J. S., Torres-Cepeda, D., Mejía-Montilla, J., & Reyna-Villasmil, N. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.04.001 · Cited by 7
Polycystic Ovary Syndrome and Insulin Resistance: New Approaches to Management, including Exercise
Laredo, S., Hannah, M. E., Casper, R. F., Feig, D. S., Leiter, L. A., & Rodgers, C. D. (2001) · Journal SOGC · doi:10.1016/s0849-5831(16)31301-5 · Cited by 7
Polycystic Ovarian Syndrome
Copperman, A. B., Mukherjee, T., & KASE, N. G. (2003) · Elsevier eBooks · doi:10.1016/b978-012053642-9/50029-6 · Cited by 7
Polycystic Ovary Syndrome
Dmitrović, R., & Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_11 · Cited by 7
The impact of insulin resistance on woman's health and potential treatment options
Lois, K. B., Valsamakis, G., Mastorakos, G. P., & Kumar, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05646.x · Cited by 7
Childhood cardiovascular health and subfertility: the Bogalusa Heart Study
Wang, Y., Xiong, X., Bazzano, L., & Harville, E. W. (2018) · Pediatric Research · doi:10.1038/s41390-018-0032-x · Cited by 6
Gonads are the heart of the matter
Speroff, L. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31803816ec · Cited by 6
CONTROVERSIES IN ENDOCRINOLOGY : A MODERN MEDICAL QUANDARY: POLYCYSTIC OVARY SYNDROME, INSULIN RESISTANCE AND ORAL CONTRACEPTIVE PILLS
Diamanti‐Kandarakis, E., Baillargeon, J., & Jurno, M. J. (2003) · Cited by 6
Síndrome de ovarios poliquísticos: abordaje diagnóstico y terapéutico
Vargas-Carrillo, M. A., Sánchez-Buenfil, G., Herrera-Polanco, J., & Vargas-Ancona, L. (2003) · REVISTA BIOMÉDICA · doi:10.32776/revbiomed.v14i3.356 · Cited by 5
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
[Chronic complications of polycystic ovary syndrome. Review].
Velásquez, E. (2002) · PubMed · Cited by 5
Conservative Management of Gynecologic Diseases
Diamanti‐Kandarakis, E., & KANDARAKIS, H. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.035 · Cited by 5
HIGH SENSITIVE C-REACTIVE PROTEIN AND APOLIPOPROTEIN B LEVELS IN POLYCYSTIC OVARY SYNDROME
Vinodhini, V. M., V.Devisri, William, W., Muthulakshmi, M., & Gnanasambandam, A. C. A. S. (2012) · International Journal of Pharma and Bio Sciences · Cited by 5
Should patients with polycystic ovarian syndrome be treated with metformin
Nestler, J. E. (2002) · Cited by 5
Betel Leaf Extract Amends Dehydroepiandrosterone Induced PCOS Related Hormonal Abnormality and Histopathological Alterations in Rat Model
Katta, S., Yellow, M., Naveen, N. P., et al. (2019) · Pharmacognosy Journal · doi:10.5530/pj.2019.11.223 · Cited by 4
“2019; 11(6)Suppl:1442-1448 A Multifaceted Journal in the field of Natural Products and Pharmacognosy www.”
Background
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00020-6 · Cited by 5
Advances in the treatment of polycystic ovary syndrome
Moghetti, P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1631 · Cited by 4
“In this regard, data concerning the prevalence of cardiovascular disease in hyperandrogenic women are limited and controversial [5-8].”
Background
New routes in the polycystic ovary syndrome labyrinth: A way out?
Moghetti, P., & Castello, R. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350793 · Cited by 3
Evaluation of Serum Homocysteine and Nitric Oxide Levels in Women with Polycystic Ovarian Syndrome and Periodontal Diseases
Hameed, D. J., & Ahmed, M. A.-A. (2017) · Tikrit Journal for Dental Sciences · doi:10.25130/tjds.5.1.8 · Cited by 3
Sex-Specific Impact of 17β-Estradiol and Testosterone Levels on Inflammation and Injury in Acute Myocardial Infarction—Preliminary Results
Semerdzhieva, N. E., Tsakova, A. D., & Lozanova, V. V. (2025) · Biomedicines · doi:10.3390/biomedicines13061466 · Cited by 3
Significance of Plasma C-peptide in Obese African American Adolescents
Williams, G. V., Gambhir, K. K., Nunlee‐Bland, G., et al. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30446-6 · Cited by 3
Polycystic Ovary Syndrome
Waldman, I. N., & Legro, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00026-1 · Cited by 6
Polycystic Ovarian Syndrome and Insulin Resistance: Implications for Estrogen Use in Premenopausal and Postmenopausal Women
Cobin, R. H. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.259 · Cited by 3
Polycystic Ovary Syndrome and the Relationship of Cardiovascular Disease Risk
Çakır, E., Çakal, E., Özbek, M., Şahi̇n, M., & Delibaşı, T. (2013) · Endocrinology research and practice. · doi:10.4274/tjem.2071 · Cited by 3
PCOS Therapy
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_6 · Cited by 3
Polycystic Ovary Syndrome and Cardiovascular Disease
Corenblum, B. (2001) · Journal SOGC · doi:10.1016/s0849-5831(16)30985-5 · Cited by 3
Diagnosis and Treatment of Heart Disease in Women
Holubkov, R., & Reís, S. E. (2000) · Elsevier eBooks · doi:10.1016/b978-012288145-9/50069-3 · Cited by 3
Sex differences in stroke
McCullough, L. D., & Sprenger‐Svačina, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22266-5.00010-0 · Cited by 1
Polycystic Ovary Syndrome
Wheeler, C. J., Keye, W. R., & Peterson, C. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1436-1_11 · Cited by 2
Polycystic Ovary Syndrome
Attaran, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00198-3 · Cited by 2
Long-Term Morbidity: Cardiovascular Disease, Cancer, and Depression in PCOS
Milman, L. W., & Dokras, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_18 · Cited by 2
“, more coronary artery segments with >50 % diameter loss) than women with normal appearing ovaries ( n = 142) [ 26 ].”
Background
HORMONE REPLACEMENT THERAPY AND CORONARY HEART DISEASE
Kuller, L. H. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70216-2 · Cited by 2
A REVIEW OF PHARMACOLOGICAL SCREENING METHODS FOR EXPERIMENTALLY INDUCED POLYCYSTIC OVARIAN DISEASE (PCOD)
Selvaraj, R. K., Jeyabalan, S., Vasu, S., Palaniyappan, V., & Settu, S. (2021) · INDIAN DRUGS · doi:10.53879/id.58.07.11836 · Cited by 1
Metabolic aspects of polycystic ovary syndrome
Wild, R. A. (1997) · Reproductive Medicine Review · doi:10.1017/s0962279900001423 · Cited by 1
Metabolic and clinical characteristics of women with self-reported symptoms of polycystic ovary syndrome
Taponen, S. (2004) · Cited by 1
EVALUATION OF THE HIGH-SENSITIVITY C-REACTIVE PROTEIN IN YOUNG OBESE WOMEN WITH PCOS
Palo, I., & Mishra, S. K. (2018) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2018/18 · Cited by 1
Polycystic Ovarian Syndrome
Dokras, A., & Sivitz, W. I. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-378-1_9 · Cited by 2
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 1
Relationship between Serum Sex Hormones and Coronary Artery Disease in Premenopausal Women – A Missing Link?
Sahu, A. K., Khanna, R., Kumar, S., et al. (2023) · Indian Journal of Cardiovascular Disease in Women · doi:10.25259/ijcdw_40_2023 · Cited by 1
The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
Sharma, S. T., & Nestler, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_10 · Cited by 1
Síndrome de ovarios poliquísticos: hiperinsulinemia relacionada con riesgo cardiovascular
Tejerizo-López, L. C., Tejerizo-García, A., Sánchez-Sánchez, M. M., García-Robles, R. M., Leiva, A., Morán, E., Corredera, F., Pérez-Escanilla, J. A., & Benavente, J. M. (2001) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/s0210-573x(01)77088-8 · Cited by 1
The Effect of Vitamin B and Folic Acid Supplementation on Plasma Homocystiene Levels in Women with Polycystic Ovary Syndrome Treated with Metformin. A Randomized Controlled Trial
Abdel, I., & Khalil, M. (2015) · Cited by 1
Polycystic ovary syndrome and cardiovascular risk
Popova, P., Gorelova, I. V., & Grineva, E. N. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2018-24-6-654-665 · Cited by 1
Polycystic ovary syndrome: ovarian pathophysiology and consequences after the menopause
Schmidt, J. G. H. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Effects of in vitro fertilization on thrombosis and haemostasis and the relationship between infertility and cardiovascular disease
Westerlund, E. (2013) · Figshare · Cited by 1
POLYCYSTIC OVARIAN SYNDROME: IS COMMUNITY CARE APPROPRIATE?
Gupta, S. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11746.x · Cited by 1
Medical management of polycystic ovarian syndrome and its sequelae
Kodaman, P. H., & Dulęba, A. J. (2006) · CRC Press eBooks · doi:10.3109/9781420042726-14 · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Infertility and reproductive endocrinology
Bieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.058 · Cited by 1
Sex-specific Impact of 17β-estradiol and Testosterone Levels on Inflammation and Injury in Acute Myocardial InfarctionPreprint
Semerdzhieva, N. E., Tsakova, A. D., Hristova, J., Lozanov, V. S., Loznova, V. V., Gospodinova, M. V., Dimitrov, S. I., Atanasov, P. Y., & Chaneva, M. S. (2023) · Preprints.org · doi:10.20944/preprints202310.0059.v1 · Cited by 1
Sex-specific Impact of 17β-estradiol and Testosterone Levels on Inflammation and Injury in Acute Myocardial InfarctionPreprint
Semerdzhieva, N. E., Tsakova, A. D., Hristova, J., Lozanov, V. S., Loznova, V. V., Gospodinova, M. V., Dimitrov, S. I., Atanasov, P. Y., & Chaneva, M. S. (2023) · Preprints.org · doi:10.20944/preprints202310.0059.v2 · Cited by 1
Acute Coronary Syndrome in Women and the Elderly
Tamis‐Holland, J. E., Weinberg, C. R., Chiadika, S. M., et al. (2008) · Springer eBooks · doi:10.1007/978-1-84628-869-2_20 · Cited by 1
Cardiovascular Risk Factors and the Development of Coronary Heart Disease in Women
von der Lohe, E. (2003) · Springer eBooks · doi:10.1007/978-3-642-55553-4_2
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519

Authors: Birdsall, M. A., Farquhar, C. M., & White, H. D.
Affiliations: University of Auckland (NZ)
Corresponding author: Birdsall, Mary A.
ORCID: White, Harvey D.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1997-01-01
Volume: 126
Issue: 1
Pages: 32-35
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-126-1-199701010-00005
OpenAlex: W1964741472
Cited by: 327
References: 0
Citations by year: 2025: 1 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 7 · 2015: 15 · 2014: 2 · 2013: 9 · 2012: 11
FWCI: 12.24
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, coronary artery disease, women, coronary angiography, coronary stenosis extent, hirsutism, free testosterone, insulin resistance, triglycerides, C-peptide, HDL cholesterol, family history of heart disease
MeSH terms: Adult, Analysis of Variance, Coronary Disease, Female, Cardiac Catheterization, Humans, Middle Aged, Polycystic Ovary Syndrome, Prospective Studies, Ultrasonography, Coronary Angiography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks